Dermatosparaxis EDS

Dermatosparaxis Ehlers-Danlos syndrome is the EDS subtype where the skin tears. The Greek roots of the name describe the phenotype: derma, skin, and sparassein, to tear or rend. The skin in dEDS is extremely fragile, sags from the body in loose folds, and lacerates from contact that would not mark unaffected skin. The condition is rare, autosomal recessive, and presents in infancy. It is the EDS subtype where everyday textures of life are more dangerous than they are for almost anyone else.

The molecular biology

Dermatosparaxis EDS is caused by biallelic variants in ADAMTS2, the gene encoding ADAMTS-2, the procollagen N-proteinase. ADAMTS-2 cleaves the N-terminal propeptide from procollagen I after the procollagen molecule has been secreted into the extracellular space. The cleavage is required for procollagen to mature into collagen and for collagen fibrils to assemble into normal-diameter, normally organized fibers.

When ADAMTS-2 activity is lost, procollagen I cannot mature. The retained N-propeptide blocks normal fibril assembly. Electron microscopy of skin from people with dEDS shows distinctive disorganized collagen fibrils with hieroglyphic cross-sections, a pattern not seen in any other EDS subtype. The mechanical consequence is skin that has lost most of its tensile strength.

The condition was first described in cattle, where ADAMTS2 dysfunction produced extreme skin fragility severe enough to be commercially important. The bovine condition was characterized before the human gene was identified, and the genetic mapping of the cattle disorder informed the search for the human gene.

Clinical features

Newborns with dEDS present with abnormally lax, fragile skin. The skin sags from the body in loose folds, particularly on the cheeks, the forearms, the abdomen, and the lower legs. Bruising is severe and routine. Skin lacerations from minor trauma, from clothing seams, from carriers, from the texture of toys, accumulate during infancy. The skin heals slowly and into wide atrophic scars.

Other features include short stature, delayed gross motor milestones, soft and doughy skin texture, generalized joint hypermobility with frequent dislocations, and, in some affected individuals, blue sclerae, hernia, and dental abnormalities. Severity varies. Some individuals have life-limiting skin fragility. Others have a milder phenotype that allows substantially normal childhoods with diligent skin protection.

A subset of people with dEDS have vascular fragility that produces arterial dissection or rupture in adulthood, a feature shared with several other EDS subtypes. The vascular phenotype is not universal in dEDS and the cohort data is limited because the condition is so rare.

Diagnosis

Diagnosis is by clinical recognition of severe neonatal skin fragility, supported by skin biopsy showing the characteristic hieroglyphic collagen fibrils on electron microscopy and confirmed by ADAMTS2 sequencing. The 2017 international classification specifies major and minor criteria.

Dermatosparaxis EDS is rare. Reported cases worldwide are in the low dozens. The true prevalence is unknown.

What management looks like

There is no FDA-approved disease-specific drug therapy. Standard of care is protective and supportive. Skin care is the central management problem. Routine practices include soft fabrics without seams or tags against the skin, padded clothing in early childhood, soft padded surfaces in nurseries and play areas, careful selection of toys to avoid hard edges, and topical care for lacerations and bruises.

Wound care emphasizes prolonged immobilization of the affected area, careful suturing with subcuticular technique that minimizes tension, and extended splinting after closure. Wounds in dEDS skin take longer to gain tensile strength than wounds in unaffected skin, and premature mobilization produces wound dehiscence. Some centers use specialized adhesive techniques and wound dressings developed for fragile skin in other contexts.

Joint management mirrors other EDS subtypes: physical therapy, bracing for unstable joints, careful activity modification, and management of chronic pain when present. Cardiac and arterial surveillance with periodic imaging is reasonable given the documented vascular phenotype in some individuals.

Genetic counseling addresses the 25 percent recurrence risk for siblings and the implications of carrier status. Prenatal testing is available when the family's specific variants are known.

What this looks like for a family

A newborn arrives with what looks like extreme generalized lax skin and a small umbilical hernia. The neonatologist notices that the skin tears at the IV puncture site, and the routine adhesive monitor pads leave an outline of skin damage when removed. Within two days the differential narrows: a connective tissue disorder, probably ADAMTS2-related, and a referral goes to medical genetics. Skin biopsy confirms the hieroglyphic fibrils on electron microscopy. ADAMTS2 sequencing returns biallelic loss-of-function variants.

The family is sent home with specialized soft clothing, a list of dressings that minimize skin trauma, instructions on bathing and lifting, and the contact information for the dermatology and genetics services that will follow the child. The first months are about learning what surfaces are safe, what fabrics are safe, what handling techniques produce the fewest tears, and what wounds need professional closure rather than home care.

That is what dermatosparaxis EDS care looks like in practice. The skin sets the schedule. Everything else accommodates it.